IN-HOUSE COMMERCIAL OPERATIONS - Co said bringing U.S. commercial operations in-house drove revenue and margin expansion
U.S. COMMERCIAL MOMENTUM - Co reported record shipment volume and 130% yr/yr increase in active prescribers in U.S.
EON CARE NETWORK - Co scaled Eon Care nurse network to cover 40% of insertion procedures, supporting growth
Analyst coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Senseonics Holdings Inc is $14.00, about 170.3% above its August 5 closing price of $5.18
Quarterly results and margin expansion
U.S. glucose monitoring tech firm's Q2 revenue rose 120% yr/yr to $14.5 mln
Gross margin expanded to 59%, up from 47% a year ago
Company raised full-year 2026 revenue and margin guidance
SENS•
